DrugApr 13, 2016
Meditech Laboratories Formula 2 recall — FDA D-0808-2016
Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.
Class IIFDA: TerminatedMeditech Laboratories, Inc.
10,690drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 271
10,690 detailed records are currently available in this category.
DrugApr 6, 2016
Zoledronic Acid Injection, 5 mg/100 mL (0.05 mg/mL), 100 mL Single Use Bottle recall — FDA D-0784-2016
Lack of Assurance of Sterility; defective seals where the metal silver ring was not attached tightly to the vial
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugMar 30, 2016
AstraZeneca Pharmaceuticals Tudorza Pressair recall — FDA D-0781-2016
Defective Delivery System: Some units have actuation counters set to a number other than 60.
Class IIFDA: TerminatedAstraZeneca Pharmaceuticals LP
DrugMar 23, 2016
Pharmedium Services NORepinephrine Bitartrate, 4 mg (16 mcg/mL) added to 250 mL 0.9% Sodium recall — FDA D-0777-2016
Subpotent Drug; confirmed results by FDA analysis after customer complaints of discoloration
Class IIIFDA: TerminatedPharmedium Services, LLC
DrugMar 23, 2016
Pharmedium Services NORepinephrine Bitartrate, 8 mg (32 mcg/mL) added to 250 mL 0.9% Sodium recall — FDA D-0778-2016
Subpotent Drug; confirmed results by FDA analysis after customer complaints of discoloration
Class IIIFDA: TerminatedPharmedium Services, LLC
DrugMar 23, 2016
Virtus Pharmaceuticals Virt-Nate Prenatal/Postnatal, Prescription Folate-Containing Dietary recall — FDA D-0775-2016
Tablets/Capsules Imprinted with Wrong ID; product debossed with an incorrect punch. Bottles could contain tablets debossed with V259 (debossing for PreTab) instead of the correct punch,…
Class IIIFDA: TerminatedVirtus Pharmaceuticals, LLC
DrugMar 23, 2016
Teva Pharmaceuticals USA Paricalcitol Capsules, 1 mcg, 30 tablets per Bottle recall — FDA D-0774-2016
Failed Impurities/Degradation Specifications: Out of specification test results for impurities during stability testing.
Class IIFDA: TerminatedTeva Pharmaceuticals USA
DrugMar 9, 2016
Capecitabine tablets USP 500 mg, Cytotoxic Agent recall — FDA D-0732-2016
Failed Dissolution Specifications: low test results at the 18 month time-point
Class IIFDA: TerminatedTeva North America
DrugMar 9, 2016
Thyrogen recall — FDA D-0730-2016
Presence of Particulate Matter: Glass particles found in the product after reconstitution.
Class IIFDA: TerminatedGenzyme Corporation
DrugMar 9, 2016
Genzyme Thyrogen recall — FDA D-0729-2016
Presence of Particulate Matter: Glass particles found in the product after reconstitution.
Class IIFDA: TerminatedGenzyme Corporation
DrugMar 9, 2016
Sun Pharma Global Fze Alendronate Sodium Tablets, USP, 70 mg*, 4-count blisters per carton recall — FDA D-0735-2016
Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point.
Class IIFDA: TerminatedSun Pharma Global Fze
DrugMar 9, 2016
J. Strickland and Co sulfur8 medicated LIGHT FORMULA (sulfur) anti-dandruff hair & scalp recall — FDA D-0734-2016
Subpotent Drug: failed at the 3 and 6 month stability time points.
Class IIIFDA: TerminatedJ. Strickland and Co
DrugMar 2, 2016
Hospira Normosol-M and 5% Dextrose recall — FDA D-0727-2016
Labeling: Incorrect or Missing Lot and/or Exp Date: Confirmed customer report of an incorrect expiration date printed on the primary container labeled "01AUG1017" rather than "01AUG2017".
Class IIIFDA: OngoingHospira Inc.
DrugMar 2, 2016
Keystone Laboratories Medicated Better Braids, La Laque (salicylic acid) Spray, 2%,12 Fl recall — FDA D-0726-2016
Microbial Contamination of a Non-Sterile Products: The product had a positive Staphylococcus aureus test result.
Class IIFDA: TerminatedKeystone Laboratories Inc.
DrugMar 2, 2016
Isomeric Pharmacy Solution Triamcinolone Diacetate Injectable Suspension, 40 mg/mL, 10mL recall — FDA D-0728-2016
Labeling: Incorrect or Missing Lot and/or Exp Date: some vials may be mislabeled with an incorrect "Compounded" date, lot number, and "Do Not Use Beyond " date or BUD (Before Use Date)…
Class IIIFDA: TerminatedIsomeric Pharmacy Solution, LLC
DrugMar 2, 2016
Zydus Pharmaceuticals USA risperiDONE ORALLY DISINTEGRATING TABLETS, 2 mg, 30 Ct Bottles recall — FDA D-0725-2016
Failed Impurities/Degradation Specifications: Out of specification for a known degradant.
Class IIIFDA: TerminatedZydus Pharmaceuticals USA Inc.
DrugFeb 24, 2016
Glades Drugs Vitamin Supplement (Vial) D3, (cholecalciferol recall — FDA D-0669-2016
Superpotent Drug: The vitamin supplement contains an extremely high level of vitamin D3 (Cholecalciferol).
Class IFDA: OngoingGlades Drugs Inc.
DrugFeb 24, 2016
Alcon Research TEARS Naturale FREE recall — FDA D-0666-2016
Lack of Assurance of Sterility: Some single-use vials may be filled with water rather than the product solution and the firm cannot guarantee the sterility of the water-filled vials.
Class IIFDA: TerminatedAlcon Research, Ltd.
DrugFeb 24, 2016
Abbott's Compounding Pharmacy progesterone/testosterone (ss oil) 0.25/20 mg/mL, 10 mL unit recall — FDA D-0715-2016
Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.
Class IIFDA: TerminatedAbbott's Compounding Pharmacy, Inc.
DrugFeb 24, 2016
Abbott's Compounding Pharmacy papaverine phentolamine prostaglandin recall — FDA D-0700-2016
Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.
Class IIFDA: TerminatedAbbott's Compounding Pharmacy, Inc.
DrugFeb 24, 2016
Abbott's Compounding Pharmacy hydroxyprogesterone w/ pres recall — FDA D-0683-2016
Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.
Class IIFDA: TerminatedAbbott's Compounding Pharmacy, Inc.
DrugFeb 24, 2016
Abbott's Compounding Pharmacy papaverine phentolamine prostaglandin recall — FDA D-0696-2016
Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.
Class IIFDA: TerminatedAbbott's Compounding Pharmacy, Inc.
DrugFeb 24, 2016
Pharmedium Services fentaNYL Citrate, Preservative Free, 10 mcg per 1 mL In 0.9% Sodium recall — FDA D-724-2016
Subpotent Drug
Class IFDA: TerminatedPharmedium Services, LLC
DrugFeb 24, 2016
Medisca CITRULLINE (L) in 25 g, 100 g, 500 g and 1 kg plastic bottles, White crystals or recall — FDA D-0674-2016
Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and results revealed no L-Citrulline was present. Levels of N-acetyl-leucine were found…
Class IFDA: TerminatedMedisca Inc.
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.